TBC1D9 and breast cancer: In addition, the dysregulation of TBC1D9 expression in BC is associated with cell proliferation disorder that leads to a non-proliferative fibrocystic change of the breast (MalaCards, Human Disease Database), a benign condition of the breast comprising fibroadenoma, cysts, fibrosis, and microcalcifications.